Pancreas Adenocarcinoma Clinical Trials

68 clinical trials for Pancreas Adenocarcinoma across international registries, including 25 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma — RECRUITING · PHASE2
• 24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC — RECRUITING · PHASE2
• Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma — RECRUITING
• Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels — RECRUITING · PHASE2
• Exercise to Improve Outcomes in Pancreatic Cancer — RECRUITING · NA
• A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring — RECRUITING
• Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy — RECRUITING · NA
• THE-0504 in Patients With Solid Tumors — RECRUITING · PHASE1
• The Role of the Human Microbiome in Patients After Pancreatic Resection. — RECRUITING
• This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer — RECRUITING · PHASE2
• Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) — RECRUITING · PHASE4
• Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer — RECRUITING · PHASE2
• Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer — RECRUITING · PHASE3
• Genetic Testing Decision Aid — RECRUITING · NA
• A Beta-only IL-2 ImmunoTherapY Study — RECRUITING · PHASE1
• Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy — RECRUITING · NA
• Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX — RECRUITING · NA
• NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101 — RECRUITING · PHASE2
• Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis — RECRUITING
• Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer — RECRUITING · NA
• Improving Pancreatic Cancer Care by the Use of Computational Science and Technology — RECRUITING
• Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma — RECRUITING · NA
• Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer — RECRUITING
• PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma — RECRUITING
• Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer — COMPLETED · PHASE1
• A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC) — NOT_YET_RECRUITING · NA
• Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy — COMPLETED
• Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy — TERMINATED
• Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) — COMPLETED · PHASE3
• Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) in Differential Diagnosis of Pancreatic Adenocarcinoma (PA) From Other Pancreatic Solid Lesions (PSLs) and Pancreatic neuroendocrinE Tumors (pNETs) Malignancy — NOT_YET_RECRUITING · NA
• CPI-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Adenocarcinoma — TERMINATED · PHASE1
• Patient-derived Organoids Drug Screen in Pancreatic Cancer — COMPLETED · NA
• Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC — WITHDRAWN · PHASE1
• A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors — COMPLETED · PHASE1
• Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC) — ACTIVE_NOT_RECRUITING · PHASE2
• Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma. — COMPLETED · NA
• Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma — TERMINATED · PHASE2
• A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors — COMPLETED · PHASE1
• CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X) — WITHDRAWN · PHASE2
• The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic Cancer — OTHER
• FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 — COMPLETED · PHASE2
• Digital Confocal Microscopy for Real-time Diagnosis of Pancreatic Solid Lesion — COMPLETED
• A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma — COMPLETED
• A Proof-of-Concept Study Evaluating LINFU™ — COMPLETED · NA
• PRECISE: Pancreatic Cancer and Exercise — COMPLETED · NA
• Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss — WITHDRAWN · PHASE1
• Pancreatic Cancer Dietary Assessment Study — COMPLETED
• 18F-FAPI PET Imaging in Pancreatic Adenocarcinoma — COMPLETED · NA

Refine this search